North Korean hackers stole data from Pfizer Covid-19, says South Korean lawmaker

Ha Tae-keung said on Tuesday that he and other lawmakers were briefed on the hack by the National Intelligence Service of South Korea, the country’s spy agency.

It is not clear when the alleged attack took place. The NIS declined to comment and Pyongyang did not publicly acknowledge the alleged theft, although North Korean diplomats generally deny any allegations of wrongdoing.

This is not the first time that North Korean cybercriminals have been accused of stealing information related to Covid-19’s treatment. Microsoft said in November that North Korea’s cyber attacks targeted vaccine manufacturers, sometimes “disguised as representatives of the World Health Organization”.

Most of the attacks were blocked, Microsoft said in a statement at the time.

Reuters reported later that month that North Korean hackers were suspected of having carried out a cyber attack against British coronavirus vaccine developer AstraZeneca, posing as recruiters and approaching the pharmaceutical company’s staff – including those working at the pharmaceutical company. Covid-19 survey – with fake job offers.

North Korea has invested heavily in recent years in offensive cyber capabilities, allowing the impoverished country to make money, attack enemies and pursue the Kim Jong Un regime’s priorities at relatively minimal expense.

The United Nations accused Pyongyang hackers of stealing $ 316.4 million worth of virtual assets between 2019 and November 2020, money that was probably used to finance the country’s nuclear and ballistic missile programs, in violation of the law. International.

It appears that the Kim regime has shifted its cyber capabilities to its efforts to prevent a pandemic and obtain a vaccine.

COVAX, an initiative to provide equitable global access to Covid-19 vaccines, said it would provide North Korea with nearly 2 million doses of the AstraZeneca-Oxford coronavirus. But North Korea is probably doing everything it can to bring a vaccine to its people, even if it means resorting to theft.

“North Koreans are taking a comprehensive approach,” said Dr. Kee B. Park, director of the Korean Health Policy Project at Harvard Medical School and the North American Program at the Korean American Medical Association. “They are trying everything – making their own, perhaps through GAVI (an organization involved in COVAX), perhaps through bilateral channels.”

North Korea’s top priority since the pandemic broke out last year has been preventing the coronavirus from overloading its dilapidated health infrastructure. Pyongyang voluntarily broke most of its meager ties to the outside world in 2020 to prevent an influx of Covid-19, including cutting off almost all trade with Beijing – a North Korean economic lifeline to prevent its people from passing hungry.

The crackdown on trade has hit the economy, but from the point of view of public health, it seems to have worked. North Korea does not appear to have experienced major Covid-19 outbreaks within its borders. North Korea says it has not registered a single case of Covid-19, a claim that most experts consider suspicious. The country tested only a fraction of its population and has a shared border with China, where the pandemic began.

Still, Kim, who is overweight and reportedly leads an unhealthy lifestyle, was confident enough to appear in public without a mask on several occasions during the pandemic.

He and his wife, Ri Sol Ju, were photographed watching a show without a mask on Tuesday. It was the first time Ri appeared in North Korean state media in over a year. Ha, the South Korean lawmaker, said South Korean intelligence believed she was acting as a precaution due to the pandemic.

The usefulness of data

It is not exactly clear what data North Korea supposedly stole from Pfizer or what North Korean scientists can do with it. North Korea said in July that it would try to develop its own coronavirus vaccine, but few believed that Pyongyang had the scientific or financial resources to carry out an effort that ended up costing billions of dollars.

Park, from Harvard Medical School, said that on a visit to North Korea he saw medical professionals giving presentations demonstrating the know-how and technology to manipulate and unite genes. However, the country may not be able to take the next crucial steps in vaccine development, he said.

With so few probable cases in North Korea, there are probably not enough infected people in the country to adequately test the effectiveness of a nationally manufactured vaccine, Park said. Conducting trials abroad, as China did, would probably be very expensive and could break UN sanctions that prevent joint ventures with the Kim regime.

Then there is the question of whether North Korea has the capacity to manufacture a vaccine on such a large scale. Pyongyang usually depends on international donors for other vaccines, such as the one that treats tuberculosis.

Finally, it is not clear how useful Pfizer’s data would be for North Korea. The Pfizer-BioNTech vaccine was the first vaccine approved for emergency use to employ MRNA technology, something that only a handful of pharmaceutical companies have been able to achieve. Those who have achieved this have spent billions doing so, according to Park.

Even if North Korea could develop an MRNA vaccine like Pfizer’s, it is unlikely that the country will have special equipment to transport and store. The Pfizer vaccine should be kept at an ultracold temperature of about 100 degrees Fahrenheit (minus 75 degrees Celsius) in order to keep the fragile MRNA material safe.

“MRNA is cutting edge technology,” said Park. “Whether or not North Korea has this kind of technology, I don’t know, but … I would be really surprised if they were able to do that. It’s something that even many developed countries are struggling with.”

CNN’s Will Ripley, Paula Hancocks and Amanda Sealy contributed to this report.

.Source